发明申请
US20030109543A1 Novel combination of an ADP-receptor blocking antiplatelet drug and a thromboxane A2 receptor antagonist and a method for inhibiting thrombus formation employing such combination
审中-公开
ADP-受体阻断抗血小板药物和血栓素A2受体拮抗剂的新型组合以及使用这种组合抑制血栓形成的方法
- 专利标题： Novel combination of an ADP-receptor blocking antiplatelet drug and a thromboxane A2 receptor antagonist and a method for inhibiting thrombus formation employing such combination
- 专利标题（中）： ADP-受体阻断抗血小板药物和血栓素A2受体拮抗剂的新型组合以及使用这种组合抑制血栓形成的方法
-
申请号： US10295347申请日： 2002-11-15
-
公开(公告)号： US20030109543A1公开(公告)日： 2003-06-12
- 发明人: Martin L. Ogletree
- 主分类号： A61K031/557
- IPC分类号： A61K031/557 ; A61K031/4743
摘要：
A method is provided for inhibiting platelet aggregation and thrombus formation by administering to a patient an ADP-receptor blocking antiplatelet drug, such as clopidogrel, in combination with a thromboxane A2 receptor antagonist, such as ifetroban, and optionally a cholesterol lowering drug, such as an HMG CoA reductase inhibitor, for example, pravastatin.
信息查询
